- Cardiac Surgery
Abeel A. Mangi, MD, is the chair of cardiac surgery for MedStar Health, based at MedStar Washington Hospital Center. He is also a professor of surgery at Georgetown University School of Medicine. Dr. Mangi is board certified in general and thoracic surgery.
Dr. Mangi specializes in complex and re-operative cardiac surgery, catheter-based and minimally invasive aortic and mitral valve repair and replacement, aortic reconstruction, and all-arterial coronary bypass grafting.
In his clinical practice, Dr. Mangi has performed thousands of heart operations with an observed-mortality-to-expected-mortality ratio of less than 0.4. His pioneering accomplishments include describing the first use of veno-arterial extracorporeal membrane oxygenation in an awake, ambulating patient as a successful bridge to lung transplantation; groundbreaking work in the area of minimally invasive cardiac valve repair and replacement; and the importance of patient selection, management and implantation techniques in left ventricular assist device implantation and cardiac transplantation.
Dr. Mangi has leveraged his experience as one of the highest volume cardiac surgeons in the country to lead and collaboratively build high volume, high quality, efficient and internationally recognized programs in heart failure and heart valve disease. He has managed 250 physicians, surgeons and staff, and revenue streams of over $400 million per year. He has managed a network of cardiac surgery across five hospitals and multiple outpatient centers. Dr. Mangi has sought out mechanisms to enhance efficiency in health care delivery and improve outcomes for patients at lower cost. Some examples of these efforts have included: optimizing blood transfusion strategies, improving patient flow through the episode of care, managing inventory, and optimizing ambulatory networks.
Dr. Mangi serves on multiple institutional, national and international committees, scientific advisory boards for Fortune 500 companies, and editorial boards. He has been elected to membership and fellowship in the most esteemed organizations in his field including the International Society for Heart and Lung Transplantation, the American College of Cardiology, the Society for Thoracic Surgeons, the Society of University Surgeons, the American College of Surgeons, the European Association for Cardiothoracic Surgery.
Dr. Mangi earned his undergraduate and medical degrees from Brown University, followed by residency in general surgery at the Massachusetts General Hospital & Harvard Medical School. He was awarded a fellowship from the National Institutes of Health to perform ground-breaking cardiac stem cell research done at the Brigham & Women's Hospital and Harvard Medical School. This work was recognized by awards from the American Heart Association and the American College of Cardiology. He completed his fellowship in cardiac surgery at Columbia University. He also holds an MBA from the Sloan School of Management at the Massachusetts Institute of Technology. Dr. Mangi has served as a cardiac surgeon at the Cleveland Clinic, and as assistant professor of surgery at Temple University where he led the heart and lung transplant programs. Most recently, Dr. Mangi was surgical director of the Structural Heart and Cardiac Valve Program for Yale New Haven Health, where he was also managing director of the Yale Cardiac Surgery Network, and director of system integration and quality.
As principal or co-investigator in almost sixty clinical trials and studies, Dr. Mangi has focused his research efforts on his specialty interests, including repair and replacement of diseased heart valves; the surgical treatment of heart failure, cellular therapy to treat advanced heart damage and expanded roles for left ventricular assist devices (LVADs). He is principal investigator on multiple NIH and industry sponsored clinical trials investigating catheter-based therapies for valvular heart disease and outcomes of patients supported on newer generation LVADs. His research budget is in excess of $12 million. More recently, his research efforts investigate the metabolic, endocrine and genetic impact of exercise in older adults recovering from heart surgery.
Dr. Mangi’s research investigates important questions regarding variables that influence clinical outcomes for therapies for cardiac patients – whether those with advanced heart valve disease or advanced heart failure. Large national databases such as the Interagency Registry for Mechanical Assisted Circulatory Support (INTERMACS), United Network for Organ Sharing (UNOS), Society for Thoracic Surgeons (STS) and the Nationwide Inpatient Sample (NIS) have been used to analyze cost and cost-effectiveness for such therapies and clinical prediction modeling. Dr. Mangi’s work has also focused on dynamic work design in the health care delivery environment and optimal rational strategies to decrease costs of care.
Dr. Mangi has been invited to speak about his clinical experience and research findings at conferences and symposia worldwide. He is the author or co-author of numerous book chapters on subjects related to his specialty interests, including advances in cardiac intensive care, cardiac surgery, assist devices and treatment of heart failure. He has authored or co-authored almost two hundred published studies in peer-reviewed publications, including Nature Medicine, The New England Journal of Medicine, Circulation, The Journal of Thoracic and Cardiovascular Surgery, and The Annals of Thoracic Surgery among others. He is Editor-in-Chief of the International Journal of Angiology.
Dr. Mangi serves on multiple institutional, national and international committees, scientific advisory boards for Fortune 500 companies, and editorial boards. He has been elected to membership and fellowship in the most esteemed organizations in his field including the International Society for Heart and Lung Transplantation, the American College of Cardiology, The Society for Thoracic Surgeons, the Society of University Surgeons, the American College of Surgeons, the European Association for Cardiothoracic Surgery.
Philosophy of Care
“I believe that each person should be treated with respect and dignity. I am thoughtful and deliberate about who I choose to operate on, always taking care to make sure that the benefits people get from heart surgery far exceed the risks they incur. I am equally deliberate about making sure that every alternative treatment strategy has been thoroughly examined before making the decision to operate on someone, in close consultation with my colleagues from cardiology and other disciplines. Ultimately, it is my goal to make sure that each patient gets the therapy that is tailored to their own unique circumstances, and that they are intimately involved with that decision making process. In my mind, that is the best way to get the best outcomes for patients.”
- Graduate Education: Massachusetts Institute of Technology (2016)
- Residency Program: Columbia Presbyterian Medical Center (2007)
- Residency Program: Columbia-Presbyterian Medical Center (2007)
- Fellowship Program: Columbia Presbyterian Medical Center (2004)
- Residency Program: Massachusetts General Hospital (2004)
- Fellowship Program: Columbia-Presbyterian Medical Center (2004)
- Internship Program: Massachusetts General Hospital (1998)
- Medical School: Brown University School of Medicine (1997)
- Aetna Innovations: HMO & EPO Plus
- Innovation Health: Indemnity
- Innovation Health: Open Network Only Plus
- Innovation Health: POS Plus
- Innovation Health: PPO
- Open EPO Plus
- Open POS II
- Aetna Elect Choice/ EPO (Aetna Health Fund) Innovation Health: Network Only Plus
- Aetna Medicare Advantage HMO & PPO Plans
- Aetna Quality Point of Service (POS)
- Aetna Student Health Insurance
- Aetna USAccess (POS)
- Aetna Worker's Compensation Network
- Blue Choice Advantage & Healthy Blue (HMO, POS)
- HealthyBlue PPO
- CFBCBS (NCA) Indemnity
- CFBCBS Blue Choice Opt Out Plus Open Access (POS)
- CFBCBS BlueChoice HMO
- CFBCBS Federal Employee Program (Std. & Basic PPO)
- CFBCBS Maryland Point of Service Plan (MPOS)
- CFBCBS Maryland Indemnity or PPO
- Choice Fund PPO
- POS OA & OA Plus
- CIGNA HMO & Network (HMO)
- CIGNA Indemnity
- CIGNA POS/Network POS
- Great-West Healthcare POS/CIGNA
- Coventry Health Care National Network PPO
- Coventry Health Care of Virginia
- Coventry of Delaware HMO/PPO
- First Health PPO
- FIRST HEALTH
- MedStar Family Choice - Maryland Health Choice
- MedStar Medicare Choice
- MedStar Select (MedStar Associates' Plan)
- Private Health Care Systems (PHCS) (PPO)
- Tricare Extra (Indemnity)
- Tricare for Life (Medicare Supplemental Plan)
- Tricare Prime
- Tricare Standard
- United Healthcare Compass (HMO)
- United Healthcare Core Essential (HMO)
- M.D. IPA (HMO)
- M.D. IPA Preferred (POS)
- Mamsi Life & Health (Indem./PPO)
- OneNet PPO, Inc.
- Optimum Choice Preferred (POS) & OCI Direct (HMO)
- United Healthcare Choice Plus
- United Healthcare Options (PPO) (includes Empire PPO, GEHA, Compass Rose)
- United Healthcare Select HMO - EPO/NPP
- United Healthcare Select Plus (POS)
- United Student Resources
- AETNA (13)
- CAREFIRST (8)
- CIGNA HEALTH CARE (6)
- COVENTRY HEALTH NETWORK (4)
- FIRST HEALTH (NOW COVENTRY) (1)
- MEDSTAR FAMILY CHOICE (1)
- MEDSTAR MEDICARE CHOICE (1)
- MEDSTAR SELECT (1)
- PRIVATE HEALTHCARE SYSTEMS, INC. (PHCS) (1)
- TRICARE (4)
- UNITED HEALTHCARE (12)
- 110 Irving Street NorthwestWashington, DC 20010
- MedStar Washington Hospital Center
- MedStar Union Memorial Hospital